v3.26.1
SEGMENT REPORTING (Details)
 3 Months Ended
Mar. 31, 2026
USD ($)
segment
Mar. 31, 2025
USD ($)
Segment Reporting [Abstract]    
Number of operating segments | segment 1  
Number of reportable segments | segment 1  
Revenues:    
Total revenues $ 51,837,000 $ 39,603,000
Operating expenses:    
Cost of goods sold 1,692,000 1,206,000
Research and development    
Research and development 14,956,000 15,078,000
Restructuring charges (394,000) 0
Selling, general and administrative    
Commercial expenses 35,425,000 40,023,000
Restructuring charges (394,000) 0
Net loss (3,642,000) (19,835,000)
Product revenue, net    
Revenues:    
Total revenues 51,771,000 39,436,000
Royalties    
Revenues:    
Total revenues 66,000 167,000
Reportable Segment    
Revenues:    
Total revenues 51,800,000 39,600,000
Operating expenses:    
Cost of goods sold 1,700,000 1,200,000
Selling, general and administrative    
Other segment expenses 19,800,000 19,900,000
Total interest and other income (expense) (3,700,000) (3,100,000)
Net loss (3,600,000) (19,800,000)
Reportable Segment | Research and development    
Research and development    
Restructuring charges (200,000) 0
Selling, general and administrative    
Restructuring charges (200,000) 0
Reportable Segment | Selling, general and administrative    
Research and development    
Restructuring charges (200,000) 0
Selling, general and administrative    
Restructuring charges (200,000) 0
Reportable Segment | Product revenue, net    
Revenues:    
Total revenues 51,800,000 39,400,000
Reportable Segment | Royalties    
Revenues:    
Total revenues 0 200,000
Reportable Segment | Research and clinical expenses    
Research and development    
Research and development 13,000,000.0 13,700,000
Reportable Segment | Chemistry, manufacturing, and control expenses    
Research and development    
Research and development 600,000 1,500,000
Reportable Segment | Commercial expenses    
Selling, general and administrative    
Commercial expenses $ 17,000,000.0 $ 20,000,000.0